Document is current
Any future updates will be listed below
-
Authors
Siemionow, Maria https://orcid.org/0000-0001-6372-6122
Malik, M.
Langa, P.
Cwykiel, J.
Brodowska, S.
Heydemann, A.
-
Funding
Funding for this research was provided by:
University of Illinois Chancellor's Innovation Fund (CIF) Proof of Concept Award
- License Information
-
More Information
Article History
First Online: 15 October 2019
Compliance with Ethical Standards
:
: MS is CMO and shareholder of Dystrogen Therapeutics SA, the company holds a license for DEC Therapy. The author declares a potential conflict of interest. MS is the inventor on the patent application filed by University of Illinois at Chicago related to chimeric cell therapy for Duchenne muscular dystrophy (WO/2016/201182). AH is the adviser to the Dystrogen Therapeutics.
: The authors MS, MM, PL, JC, SB and AH do not have any non-financial conflict of interest.
